Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel Stromal Cell Therapy for Diabetic Kidney Disease (NEPHSTROM Study)

NCT02585622 is registered in ClinicalTrials.gov with Mario Negri Institute for Pharmacological Research as lead sponsor.

NCT NCT02585622
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02585622 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel Stromal Cell Therapy for Diabetic Kidney Disease (NEPHSTROM Study)
Lead sponsor
Mario Negri Institute for Pharmacological Research
Phase
Phase 1/2
Overall status
Terminated
Start date
December 11, 2017
Completion date
January 3, 2024
Enrollment
29 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

diabetic kidney disease